Literature DB >> 9350818

Marshall-Smith syndrome: the expanding phenotype.

D K Williams1, D R Carlton, S H Green, K Pearman, T R Cole.   

Abstract

We report a child of 3 years 9 months with the Marshall-Smith syndrome (MSS), characterised by the typical facial features, developmental delay, and advanced bone age. After the diagnosis was made at 5 months of age, careful observation for respiratory complications and failure to thrive was initiated. By 3 1/2 years of age, although our patient had no life threatening respiratory complications, investigation showed significant upper airway obstruction, which has been successfully treated. Aggressive treatment for failure to thrive has also allowed her to maintain a weight on the 50th centile. The purpose of this report is to suggest that early diagnosis and aggressive management may improve the ultimate prognosis with respect to the respiratory and feeding difficulties seen in this rare syndrome.

Entities:  

Mesh:

Year:  1997        PMID: 9350818      PMCID: PMC1051092          DOI: 10.1136/jmg.34.10.842

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  7 in total

1.  The Marshall-Smith syndrome.

Authors:  A Charon; Y Gillerot; L Van Maldergem; M H Van Schaftingen; B de Bont; L Koulischer
Journal:  Eur J Pediatr       Date:  1990-11       Impact factor: 3.183

2.  Syndrome of accelerated skeletal maturation in infancy, peculiar facies, and multiple congenital anomalies.

Authors:  N Visveshwara; N Rudolph; D Dragutsky
Journal:  J Pediatr       Date:  1974-04       Impact factor: 4.406

3.  Accelerated skeletal maturation in infancy syndrome: report of a third case.

Authors:  R E Tipton; R S Wilroy; R L Summitt
Journal:  J Pediatr       Date:  1973-11       Impact factor: 4.406

4.  Extreme upper airway obstruction with the Marshall syndrome.

Authors:  R LaPenna; G M Folger
Journal:  Clin Pediatr (Phila)       Date:  1982-08       Impact factor: 1.168

5.  Marshall-Smith syndrome: two case reports and a review of pulmonary manifestations.

Authors:  J P Johnson; J C Carey; F J Glassy; T Paglieroni; M H Lipson
Journal:  Pediatrics       Date:  1983-02       Impact factor: 7.124

6.  Long survival of a patient with Marshall-Smith syndrome without respiratory complications.

Authors:  D Sperli; D Concolino; C Barbato; P Strisciuglio; G Andria
Journal:  J Med Genet       Date:  1993-10       Impact factor: 6.318

7.  Marshall-Smith syndrome: new radiographic, clinical, and pathologic observations.

Authors:  G F Eich; M M Silver; R Weksberg; A Daneman; T Costa
Journal:  Radiology       Date:  1991-10       Impact factor: 11.105

  7 in total
  5 in total

Review 1.  Marshall-Smith syndrome: case report of a newborn male and review of the literature.

Authors:  D A Summers; H A Cooper; M G Butler
Journal:  Clin Dysmorphol       Date:  1999-07       Impact factor: 0.816

2.  Marshall-Smith syndrome.

Authors:  T E Herman; M J Siegel
Journal:  J Perinatol       Date:  2015-04       Impact factor: 2.521

3.  Treatment of refractory hip pain with sodium hyaluronate (Hyalgan(c)) in a patient with the Marshall-Smith Syndrome: A case report.

Authors:  Matthew Salter; Chandoo Kalmat; Henry Kroll; David Kim
Journal:  J Orthop Surg Res       Date:  2010-08-23       Impact factor: 2.359

Review 4.  Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour.

Authors:  R H Scott; C A Stiller; L Walker; N Rahman
Journal:  J Med Genet       Date:  2006-05-11       Impact factor: 6.318

5.  Array-based comparative genomic hybridization identifies a high frequency of copy number variations in patients with syndromic overgrowth.

Authors:  Valérie Malan; Suzanne Chevallier; Gwendoline Soler; Christine Coubes; Didier Lacombe; Laurent Pasquier; Jean Soulier; Nicole Morichon-Delvallez; Catherine Turleau; Arnold Munnich; Serge Romana; Michel Vekemans; Valérie Cormier-Daire; Laurence Colleaux
Journal:  Eur J Hum Genet       Date:  2009-10-21       Impact factor: 4.246

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.